ENT Pathogens

Rapid Detection of ENT Pathogens

HealthTrackRx (HTRx) is the premier specialty diagnostic laboratory dedicated to the detection of infectious diseases.

With a decades-long track record of industry-leading technological advancement, our assays deliver accurate, actionable data with best-in-class turnaround time.

99% of samples received by our lab are reported out within 24-36 hours of receipt.

Eliminate the Guesswork in Diagnosis and Treatment

Our ENT pathogen assay utilizes the latest in quantitative RT-PCR technology to rapidly and reliably analyze your patient’s sample.

We rapidly detect and differentiate 98-99% of the most relevant viral, bacterial, and fungal otolaryngology pathogens, including Influenza, Aspergillus, Moraxella, and Rhizopus.

Our molecular technique provides a more definitive diagnosis than POC antigen assays and most common ENT tests*

Our ENT Diagnostics:

  • Reduce false negatives
  • Detect polymicrobial infections
  • Include one of the most extensive antibiotic resistance gene menus
  • Are unaffected by concurrent antibiotic use
  • Report within 24-36 hours of sample receipt

Prescribe with Confidence

As the leader in testing sensitivity and specificity, our reports include a custom-designed accurate and detailed antibiogram.

  • Support antibiotic stewardship by reducing over-utilization of broad-spectrum anti-infectives
  • Decrease the need for empiric therapy
  • Reduce unnecessary drug exposure, adverse events, cost of repeat testing, and multiple treatment attempts

The New 99%

  • Over 99% of results are reported within 24-36 hours of sample receipt

  • Over 99% sensitivity to reduce false negatives

  • Over 99% specificity to reduce false positives

  • Over 99% of the most common pathogens detected

  • 100% trackable samples and results

ENT Pathogens

  • Acinetobacter baumanii

  • Adenovirus HAdV-B

  • Aspergillus flavus, fumigatus, niger, terreus

  • Candida albicans, glabrata, parapsilosis, tropicalis

  • Candida Auris

  • Chlamydia trachomatis

  • Chlamydophila pneumoniae

  • Coronavirus (229E, NL63, OC43, and HKU1)

  • COVID-19 Coronavirus (SARS-CoV-2)

  • Cytomegalovirus (CMV, Human Herpesvirus-5)

  • Escherichia coli

  • Enterobacter aerogenes, cloacae

  • Enterovirus A, B, C

  • Enterovirus D68

  • Haemophilus influenzae

  • Human metapneumovirus

  • Influenza virus A, B

  • Klebsiella pneumoniae, oxytoca

  • Moraxella catarrhalis

  • Mycoplasma genitalium, hominis

  • Mycoplasma pneumoniae

  • Neisseria gonorrhoeae

  • Parainfluenza virus (types 1, 2, 3, 4)

  • Proteus mirabilis, vulgaris

  • Pseudomonas aeruginosa

  • Respiratory syncytial virus

  • Rhinovirus A, B, C

  • Rhizopus spp, Mucor spp.

  • Serratia marcescens

  • Staphylococcus spp

  • Staphylococcus aureus

  • Streptococcus agalactiae (Group B Strep͘ (GBS))

  • Streptococcus pneumoniae

  • Streptococcus pyogenes (Group A Strep͘ (GAS))

  • Ureaplasma urealytcum, parvum

Antibiotic Resistance

  • VanA, VanB (Vancomycin genes)

  • ermB, c; mefA

  • SHV, KPC Groups

  • CTX-M1 (15), M2 (2), M9 (9), M8/25 Groups

  • dfr (A1, A5), sul (1, 2) probes

  • mecA (Methicillin gene)

  • qnrA1, qnrA2, qnrB2

  • tet B, tet M (Tetracycline genes)

  • IMP, NDM, VIM Groups

  • ACT, MIR, FOX, ACC Groups

  • OXA-48, -51 (Class D oxacillinase)

Effective 7/20/2020

*Torres, A., Lee, N., Cilloniz, C, et al. (2016 Nov 3). Laboratory diagnosis of pneumonia in the molecular age. European Respiratory Journal 48: 1764-1778. http://ow.ly/2aJh304NuCn

Learn More

Ready to improve outcomes with faste, accurate diagnostic results? Contact us to learn more.

Click below to schedule your consultation.

Schedule A Consultation